Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolensa vs Ilevro for post-cataract surgery inflammation
NCT01847638Phase 4Completed
- Start
- Apr 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bromfenac sodium in ocular inflammation, macular edema. Started Apr 2013; status: completed.
02
Drugs
bromfenac sodium
03
Conditions
ocular inflammationmacular edema
Beyond the preview
Go deeper on NCT01847638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847638.